- Home
- VLOS vs CLLS Comparison
VLOS vs CLLS Comparison
Compare VLOS & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.42
Company Overview
Basic Information| Metric | VLOS | CLLS |
|---|---|---|
| Founded | 2024 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.1M | 394.4M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VLOS | CLLS |
|---|---|---|
| Price | $10.72 | $1.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.33 |
| AVG Volume (30 Days) | 60.2K | ★ 171.9K |
| Earning Date | 08-13-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.55 | $1.25 |
| 52 Week High | $10.90 | $5.48 |
Technical Indicators
Market Signals| Indicator | VLOS | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 26.03 |
| Support Level | N/A | $1.31 |
| Resistance Level | $10.73 | $3.47 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 52.94 | 17.81 |
Price Performance
Historical Comparison VLOS
CLLS
About VLOS Velos Acquisition I Corp. Class A Ordinary shares
Velos Acquisition I Corp, formerly M3-Brigade Acquisition V Corp, is a blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.